REVVITY, INC. — fact timeline

REVVITY, INC. reported first quarter ended April 5, 2026 results: revenue $711 million, EPS $0.37.

“OR IMMEDIATE RELEASE May 5, 2026 Revvity Announces Financial Results for the First Quarter of 2026 • Revenue of $711 million; pro forma revenue of $687 million; 7% revenue growth; 3% organic gro wth; 6% pro forma organic growth • GAAP EPS from continuing operations of $0.37 ; adjusted EPS from continuing operations of $1.06 ; GAAP pro forma EPS from continuing operations of $0.40; pro forma adjusted EPS from continuing operations of $1.04 • Announces intention to divest China Immunodiagnostics business • Updates full year 2026 guidance WALTHAM, Mass.”

REVVITY, INC. shareholders rejected Shareholder proposal regarding executive stock ownership at the 2026-04-28 meeting.

“Proposal #5- Shareholder proposal regarding executive stock ownership. For Against Abstain Broker Non-Votes 22,974,850 76,502,157 124,554 4,512,033”

REVVITY, INC. shareholders approved To amend the Company's Amended and Restated By-laws to allow shareholders owning 25% of the Company's common stock to call a special meeting of shareholders at the 2026-04-28 meeting.

“Proposal #4 – To amend the Company's Amended and Restated By-laws to allow shareholders owning 25% of the Company's common stock to call a special meeting of shareholders. For Against Abstain Broker Non-Votes 99,086,661 440,300 74,600 4,512,033”

REVVITY, INC. shareholders approved To approve, by non-binding advisory vote, the Company's executive compensation at the 2026-04-28 meeting.

“Proposal #3 – To approve, by non-binding advisory vote, the Company's executive compensation. For Against Abstain Broker Non-Votes 94,377,138 3,770,364 1,454,059 4,512,033”

REVVITY, INC. shareholders approved To ratify the selection of Deloitte & Touche LLP as the Company's independent public accounting firm for the current fiscal year at the 2026-04-28 meeting.

“Proposal #2 – To ratify the selection of Deloitte & Touche LLP as the Company's independent public accounting firm for the current fiscal year. For Against Abstain Broker Non-Votes 102,992,151 1,036,994 84,449 0”

REVVITY, INC. shareholders approved Election of directors at the 2026-04-28 meeting.

“Proposal #1 – To elect the following nominees as our directors for terms of one year each: Name Votes in Favor Votes Against Abstentions Broker Non-Votes Peter Barrett, PhD 93,823,710 5,674,907 102,944 4,512,033”

REVVITY, INC.: Amended bylaws to allow shareholders owning 25% of common stock to call a special meeting (effective 2026-04-28).

“At the annual meeting of shareholders of Revvity, Inc. (the “Company”) held on April 28, 2026, the shareholders voted on and approved a proposal to amend the Company’s Amended and Restated By-laws (prior to such amendment and restatement, the “Prior By-laws”) to allow shareholders owning 25% of the Company’s stock to call a special meeting of shareholders (as amended and restated, the “Amended and Restated By-laws”) effective as of April 28, 2026.”

REVVITY, INC. reported first quarter ended March 31, 2024 results: revenue $650 million, EPS $0.21. Guidance reaffirmed.

“reference in such a filing. --- EX-99.1 (EX-99.1) --- FOR IMMEDIATE RELEASE April 29, 2024 Revvity Announces Financial Results for the First Quarter of 2024 • Revenue of $650 million; (4)% reported growth; (3)% organic growth • First quarter GAAP EPS of $0.21; Adjusted EPS from continuing operations of $0.98 • Reaffirms full year 2024 organic growth and”

REVVITY, INC. shareholders approved Shareholder proposal to adopt a simple majority voting standard at the 2024-04-23 meeting.

“Proposal #4 – Shareholder proposal to adopt a simple majority voting standard. For Against Abstain Broker Non-Votes 98,737,249 3,439,994 629,839 4,412,668”

REVVITY, INC. shareholders approved Advisory vote to approve executive compensation at the 2024-04-23 meeting.

“Proposal #3 – To approve, by non-binding advisory vote, the Company’s executive compensation. For Against Abstain Broker Non-Votes 97,992,794 4,439,860 374,428 4,412,668”

REVVITY, INC. shareholders approved Ratification of selection of Deloitte & Touche LLP as independent registered public accounting firm for the current fiscal year at the 2024-04-23 meeting.

“Proposal #2 – To ratify the selection of Deloitte & Touche LLP as the Company’s independent public accounting firm for the current fiscal year. For Against Abstain Broker Non-Votes 100,434,538 6,710,376 74,836 0”

REVVITY, INC. shareholders approved Election of ten nominees for director for terms of one year each at the 2024-04-23 meeting.

“Proposal #1 – To elect the following nominees as our directors for terms of one year each: Name Votes in Favor Votes Against Abstentions Broker Non-Votes Peter Barrett, PhD 98,617,347 4,120,162 69,573 4,412,668 Samuel R. Chapin 101,875,015 796,619 135,448 4,412,668 Michael A. Klobuchar 102,480,081 180,975 146,026 4,412,668 Michelle McMurray-Heath, MD, PhD 102,142,236 597,229 67,617 4,412,668 Alexis P. Michas 100,947,761 1,800,119 59,202 4,412,668 Prahlad R. Singh, PhD 102,298,878 438,353 69,851 4,412,668 Sophie V. Vandebroek, PhD 102,553,295 185,366 68,421 4,412,668 Michael Vounatsos 99,620,162 3,071,552 115,368 4,412,668 Frank Witney, PhD 98,711,364 4,027,568 68,150 4,412,668 Pascale Witz 101,924,209 812,393 70,480 4,412,668”

Sophie V. Vandebroek was elected as Director at REVVITY, INC..

“On January 25, 2024, the Board elected Michael A. Klobuchar and Sophie V. Vandebroek to serve on the Board, effective February 1, 2024.”

Michael A. Klobuchar was elected as Director at REVVITY, INC..

“On January 25, 2024, the Board elected Michael A. Klobuchar and Sophie V. Vandebroek to serve on the Board, effective February 1, 2024.”

Dr. Sylvie Grégoire departed as Director at REVVITY, INC..

“On January 25, 2024, Dr. Sylvie Grégoire, a member of the Board of Directors (the “Board”) of Revvity, Inc. (“Revvity” or the “Company”) notified the Company of her decision not to stand for re-election to the Board at the annual meeting of shareholders of the Company scheduled to occur on April 23, 2024.”

REVVITY, INC. reported fourth quarter ended December 31, 2023 results: revenue at least $690 million.

“Revenue for the fourth quarter is expected to be at least $690 million”

REVVITY, INC. reported third quarter ended October 1, 2023 results: revenue $671 million, EPS GAAP EPS of $0.08; Adjusted EPS from continuing operations of $1.18.

“Revvity Announces Financial Results for the Third Quarter of 2023 Revenue of $671 million; (6)% reported growth; (7)% organic growth; 1% non-COVID organic growth GAAP EPS of $0.08; Adjusted EPS from continuing operations of $1.18 Updates full year 2023 guidance”

REVVITY, INC. reported second quarter ended July 2, 2023 results: revenue $709 million, EPS GAAP EPS of $0.28.

“Revvity Announces Financial Results for the Second Quarter of 2023 Revenue of $709 million; (21)% reported growth; (20)% organic growth; 6% non-COVID organic growth GAAP EPS of $0.28; Adjusted EPS from continuing operations of $1.21 Updates full year 2023 guidance”

REVVITY, INC. reported the first quarter ended April 2, 2023 results: revenue $675 million, EPS $4.50. Guidance reaffirmed.

“Revvity, Inc. (NYSE: PKI), today reported financial results for the first quarter ended April 2, 2023. The Company reported GAAP earnings per share of $4.50, as compared to $1.40 in the same period a year ago. GAAP revenue for the quarter was $675 million, as compared to $963 million in the same period a year ago.”

REVVITY, INC.: Board of directors approved an amendment and restatement of the bylaws to, among other updates, reflect the name change, effective April 26, 2023 (effective 2023-04-26).

“In connection with the Name Change, the board of directors of the Company approved an amendment and restatement of the Company’s Amended and Restated By-laws (prior to such amendment and restatement, the “Prior By-laws”) to, among other updates, reflect the Name Change (as amended and restated, the “Amended and Restated By-laws”) effective as of April 26, 2023.”

REVVITY, INC.: Company amended its restated articles of organization to change its name from 'PerkinElmer, Inc.' to 'Revvity, Inc.' effective April 26, 2023 (effective 2023-04-26).

“Following the approval of the Company’s shareholders and effective as of April 26, 2023, the Company amended its restated articles of organization, as amended, to effect a change of the Company’s name from “PerkinElmer, Inc.” to “Revvity, Inc.” (the “Name Change”).”

REVVITY, INC. shareholders approved Amendment to restated articles of organization to change company name to Revvity, Inc. at the 2023-04-25 meeting.

“Proposal #5 - To approve the amendment of the Company’s restated articles of organization, as amended, to change the name of the Company from “PerkinElmer, Inc.” to “Revvity, Inc.” For Against Abstain Broker Non-Votes 111,054,945 801,605 666,527 0”

REVVITY, INC. shareholders approved Non-binding advisory vote on frequency of future executive compensation advisory votes at the 2023-04-25 meeting.

“Proposal #4 – To recommend, by non-binding advisory vote, the frequency of future executive compensation advisory votes. 1 Year 2 Years 3 Years Abstain Broker Non-Votes 99,492,023 41,009 6,101,017 379,569 6,509,459”

REVVITY, INC. shareholders approved Non-binding advisory vote to approve executive compensation at the 2023-04-25 meeting.

“Proposal #3 – To approve, by non-binding advisory vote, the Company’s executive compensation. For Against Abstain Broker Non-Votes 100,542,538 5,082,669 388,411 6,509,459”

REVVITY, INC. shareholders approved Ratification of selection of Deloitte & Touche LLP as independent registered public accounting firm at the 2023-04-25 meeting.

“Proposal #2 – To ratify the selection of Deloitte & Touche LLP as the Company’s independent public accounting firm for the current fiscal year. For Against Abstain Broker Non-Votes 107,124,256 5,254,729 144,092 0”

REVVITY, INC. shareholders approved Election of nine nominees for director at the 2023-04-25 meeting.

“Proposal #1 – To elect the following nominees as our directors for terms of one year each: Name Votes in Favor Votes Against Abstentions Broker Non-Votes Peter Barrett, PhD 102,367,661 3,562,139 83,818 6,509,459 Samuel R. Chapin 104,838,554 1,090,624 84,440 6,509,459 Sylvie Grégoire, PharmD 104,244,930 1,632,293 136,395 6,509,459 Michelle McMurray-Heath, MD, PhD 105,569,324 370,740 73,554 6,509,459 Alexis P. Michas 103,442,991 2,413,538 58,514 6,509,459 Prahlad R. Singh, PhD 105,480,309 450,491 82,818 6,509,459 Michael Vounatsos 104,142,844 1,718,229 152,545 6,509,459 Frank Witney, PhD 102,323,514 3,590,126 99,978 6,509,459 Pascale Witz 104,714,460 1,210,436 88,722 6,509,459”

REVVITY, INC. completed a disposition involving PerkinElmer Topco, L.P. (formerly known as Polaris Purchaser, L.P.), owned by funds managed by affiliates of New Mountain Capital L.L.C. for approximately $2.136 billion (closed 2023-03-13).

“On March 13, 2023, the Company completed its sale of the Business (not including the Deferred Businesses) to the Purchaser pursuant to the A&R Purchase Agreement. The aggregate consideration paid for the Business at the closing was approximately $2.136 billion”

REVVITY, INC. amended Amended and Restated Master Purchase and Sale Agreement with PerkinElmer Topco, L.P. (formerly known as Polaris Purchaser, L.P.) valued at $75 million (effective 2023-03-11).

“On March 11, 2023, PerkinElmer, Inc. (the “Company”) entered into an Amended and Restated Master Purchase and Sale Agreement (the “A&R Purchase Agreement”) with PerkinElmer U.S. LLC, a Delaware limited liability company and wholly-owned indirect subsidiary of the Company (“PKI US LLC”) and PerkinElmer Topco, L.P. (formerly known as Polaris Purchaser, L.P.) (the “Purchaser”), a Delaware limited partnership owned by funds managed by affiliates of New Mountain Capital L.L.C., which amended and restated the terms of the previously disclosed Master Purchase and Sale Agreement, dated as of August 1, 2022, by and among the Company and the Purchaser (the “Original Agreement”)”

REVVITY, INC. reported the fourth quarter and full year ended January 1, 2023 results: revenue $741 million, EPS $0.85. Guidance initiated.

“EXHIBIT 99.1 Exhibit 99.1 PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year of 2022 Fourth quarter revenue from continuing operations of $741 million; (28)% reported growth; (23)% organic growth; 8% non-COVID organic growth Combined* total fourth quarter revenue of $1,089 million; 8% combined non-COVID organic growth Fourth”

REVVITY, INC. updated its fourth quarter ended January 1, 2023 guidance (reaffirmed).

“On January 9, 2023, PerkinElmer, Inc. (the “Company”) announced preliminary expectations with respect to certain financial results for the fourth quarter ended January 1, 2023”

REVVITY, INC. reported the third quarter ended October 2, 2022 results: revenue $712 million, EPS $0.55. Guidance initiated.

“(EXHIBIT 99.1) --- EX-99.1 2 a52961763ex99_1.htm EXHIBIT 99.1 Exhibit 99.1 PerkinElmer Announces Financial Results for the Third Quarter of 2022 Third quarter revenue of $712 million; (17)% reported growth Pro forma* total revenue of $1,033 million; 9% pro forma non-COVID organic growth Third quarter GAAP EPS from continuing operations of $0.55; pro forma”

Maxwell Krakowiak was appointed as Senior Vice President and Chief Financial Officer at REVVITY, INC..

“On August 16, 2022, the Company’s Board of Directors (the “Board”) appointed Maxwell Krakowiak to serve as its Senior Vice President and Chief Financial Officer, effective as of September 6, 2022.”

James M. Mock resigned as Senior Vice President and Chief Financial Officer at REVVITY, INC..

“James M. Mock, the Senior Vice President and Chief Financial Officer of PerkinElmer, Inc. (“PerkinElmer” or the “Company”), notified the Company that he is resigning as the Company’s Chief Financial Officer and terminating his employment effective as of September 5, 2022.”

Dr. Michelle McMurry-Heath was elected as Director at REVVITY, INC..

“On July 22, 2022, the Board of Directors (the “Board”) of PerkinElmer, Inc. (“PerkinElmer” or the “Company”) elected Dr. Michelle McMurry-Heath to serve on the Board, effective immediately.”